Asston Pharmaceuticals Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Asston Pharmaceuticals Ltd is ₹ 79.94 as of 08 May 15:30 . The p/e ratio of Asston Pharmaceuticals Ltd changed from 0 to 0 over 6 quarters. This represents a CAGR of 0.0% The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 0 over 5 quarters. This represents a CAGR of -100.00% The market cap of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The revenue of Asston Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The ebitda of Asston Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The net profit of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The dividend payout of Asston Pharmaceuticals Ltd changed from 0 % to 0 % over 6 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 6 quarters. This represents a CAGR of -100.00% .

About Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products. Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Asston Pharmaceuticals Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Asston Pharmaceuticals Ltd is 68 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,992 Cr

What are the key factors driving the stock performance of Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 8, 2026, the Asston Pharmaceuticals Ltd stock price is INR ₹79.94. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4773.0.

How do dividend payouts of Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Asston Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.